Breaking barriers with tofersen: Enhancing therapeutic opportunities in amyotrophic lateral sclerosis

被引:13
作者
Saini, Aniket [1 ]
Chawla, Pooja A. [1 ,2 ]
机构
[1] ISF Coll Pharm, Dept Pharmaceut Anal, Moga, Punjab, India
[2] ISF Coll Pharm, Dept Pharmaceut Chem & Anal, Moga 142001, Punjab, India
关键词
ALS; adverse drug reactions; amyotrophic lateral sclerosis; clinical trial; FDA-approved drugs; tofersen; ANTISENSE OLIGONUCLEOTIDE TOFERSEN; ALS-LINKED SOD1; SUPEROXIDE-DISMUTASE; MUTANT SOD1; ER STRESS; MUTATIONS; SURVIVAL; DISEASE; TRIAL; AGGREGATION;
D O I
10.1111/ene.16140
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and purposeAmyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that primarily affects adults, characterized by muscle weakness resulting from the specific death of motor neurons in the spinal cord and brain. The pathogenesis of ALS is associated with the accumulation of mutant superoxide dismutase 1 (SOD1) proteins and neurofilaments in motor neurons, highlighting the critical need for disease-modifying treatments. Current therapies, such as riluzole and edaravone, provide only symptomatic relief. Recently, tofersen gained approval from the US FDA under the brand name Qalsody as the first and only gene therapy for ALS, addressing a significant pathological aspect of the disease.MethodsWe carried out a literature survey using PubMed, Scopus, National Institutes of Health, and Biogen for articles published in the English language concerned with "amyotrophic lateral sclerosis", pathophysiology, current treatment, treatment under clinical trial, and the newly approved drug "tofersen" and its detailed summary.ResultsA comprehensive review of the literature on the pathophysiology, available treatment, and newly approved drug for this condition revealed convincing evidence that we are now able to better monitor and treat ALS.ConclusionsAlthough treatment of ALS is difficult, the newly approved drug tofersen has emerged as a potential therapy to slow down the progression of ALS by targeting SOD1 mRNA, representing a significant advancement in the treatment of ALS.
引用
收藏
页数:11
相关论文
共 50 条
[21]   Amyotrophic lateral sclerosis [J].
Ludolph, Albert C. ;
Brettschneider, Johannes ;
Weishaupt, Jochen H. .
CURRENT OPINION IN NEUROLOGY, 2012, 25 (05) :530-535
[22]   Prognostic categories for amyotrophic lateral sclerosis [J].
Scotton, William J. ;
Scott, Kirsten M. ;
Moore, Dan H. ;
Almedom, Leeza ;
Wijesekera, Lokesh C. ;
Janssen, Anna ;
Nigro, Catherine ;
Sakel, Mohammed ;
Leigh, Peter N. ;
Shaw, Chris ;
Al-Chalabi, Ammar .
AMYOTROPHIC LATERAL SCLEROSIS, 2012, 13 (06) :502-508
[23]   Clinical studies in amyotrophic lateral sclerosis [J].
Dorst, Johannes ;
Genge, Angela .
CURRENT OPINION IN NEUROLOGY, 2022, 35 (05) :686-692
[24]   Genetics of amyotrophic lateral sclerosis: A review [J].
Mathis, Stephane ;
Goizet, Cyril ;
Soulages, Antoine ;
Vallat, Jean-Michel ;
Le Masson, Gwendal .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 399 :217-226
[25]   Trehalose delays the progression of amyotrophic lateral sclerosis by enhancing autophagy in motoneurons [J].
Castillo, Karen ;
Nassif, Melissa ;
Valenzuela, Vicente ;
Rojas, Fabiola ;
Matus, Soledad ;
Mercado, Gabriela ;
Court, Felipe A. ;
van Zundert, Brigitte ;
Hetz, Claudio .
AUTOPHAGY, 2013, 9 (09) :1308-1320
[26]   Considerations on breaking the news in amyotrophic lateral sclerosis [J].
Borasio, GD ;
Pongratz, DE .
NERVENARZT, 1997, 68 (12) :1004-1007
[27]   5-Hydroxytryptamine: a potential therapeutic target in amyotrophic lateral sclerosis [J].
Jiang, Shi-Shi ;
Gong, Meng-Ni ;
Rao, Wei ;
Chai, Wen ;
Chen, Wen-Zhi ;
Zhang, Xiong ;
Nie, Hong-Bing ;
Xu, Ren-Shi .
NEURAL REGENERATION RESEARCH, 2023, 18 (09) :2047-2055
[28]   Inflammatory checkpoints in amyotrophic lateral sclerosis: From biomarkers to therapeutic targets [J].
Jiang, Zongzhi ;
Wang, Ziyi ;
Wei, Xiaojing ;
Yu, Xue-Fan .
FRONTIERS IN IMMUNOLOGY, 2022, 13
[29]   Advancements in Pharmacological Interventions and Novel Therapeutic Approaches for Amyotrophic Lateral Sclerosis [J].
Montiel-Troya, Maria ;
Mohamed-Mohamed, Himan ;
Pardo-Moreno, Teresa ;
Gonzalez-Diaz, Ana ;
Ruger-Navarrete, Azahara ;
Fernandez, Mario de la Mata ;
Tovar-Galvez, Maria Isabel ;
Ramos-Rodriguez, Juan Jose ;
Garcia-Morales, Victoria .
BIOMEDICINES, 2024, 12 (10)
[30]   Changes in Cerebrospinal Fluid Concentrations of Selenium Species Induced by Tofersen Administration in Subjects with Amyotrophic Lateral Sclerosis Carrying SOD1 Gene Mutations [J].
Vinceti, Marco ;
Urbano, Teresa ;
Filippini, Tommaso ;
Bedin, Roberta ;
Simonini, Cecilia ;
Soraru, Gianni ;
Trojsi, Francesca ;
Michalke, Bernhard ;
Mandrioli, Jessica .
BIOLOGICAL TRACE ELEMENT RESEARCH, 2025, 203 (04) :2355-2364